Search

everythinglearnresearchcommunity

for

Search:↓

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Testosterone reduces key molecules needed for early pregnancy in rats.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

IsoPSA test works accurately even if patients take certain prostate medications.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Stopping the beta-blocker nadolol led to quick hair regrowth and improved scalp condition.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

One minoxidil-sensitive potassium channel exists in human hair follicles.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Some common medications can harm male fertility, but many effects can be reversed.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.